FortiFi™ - Clinical Trials
|I Product Info||I Ingredients
||I Recommended Use
||I Clinical Trials
||I Research Brief
Low USA domestic & international
Indication: unbalanced diet, constipation, dysbacteriosis, food poisoning, general fatigue, increased cholesterol levels, increased body weight, skin problems, body cleanse.
Actions: colon cleanse, stimulates bowel movements, essential for the healthy cardiovascular system, helps to get lower cholesterol levels, regulate blood sugar levels, slow down the absorption of fats and carbohydrates, normalize intestine microflora, helps with body detoxification, normalizes metabolism, helps in weight control, decreases the appetite by promoting the sense of fullness in the stomach.
Ingredients (per 1 packet):
Proprietary Blend – 9,8000 mg: Psyllium (Plantago psyllium) husk powder, Apple Pectin powder, Spirulina (Spirulina platensis) powder, Tomato (Solanum aesculentum) powder, Carrot (Daucus carota) powder, Parsley (Petroselinum crispum) leaf powder, Broccoli (Brassica oleracea var. italica) powder, Chlorella powder, Spinach (Spinacia oleracea) powder, Celery (Apium graveolens) (stalk & leaf) powder, Kale (Brassica oleracea var. acephala) powder, Cranberry (Oxycoccus palustris) powder, Beet (Beta vulgaris) root powder, Pineapple juice (Ananas comosus) powder, Malic Acid.
FortiFi™ - Clinical Trials:
More than 150 clinical trials were conducted with the purpose to determine the influence of dietary fibers on the condition of cardio-vascular system.
The increased cholesterol level is one of the major risk factors of coronary heart diseases. The findings demonstrated that soluble fiber reduces the risk of heart disease by lowering cholesterol. Soluble fibers decrease the bile absorption process. Bile, which contains cholesterol, is necessary for the digestion of fat. It is secreted into the intestine in response to food intake and most of it is reabsorbed after digestion is completed, when soluble fiber is present not as much bile is reabsorbed. (5)
The research conducted in Netherlands showed that men using insufficient amount of dietary fibers are four times more susceptible to fatal results of CVD. The daily dietary fiber intake should be no less than 37 mg per day.
Burkitt et al, in 1972, compared various population groups and found that those on high fiber diets produced stools of 150- 980 grams/day, with transit times of 19-68 hours. Those on low fiber produced stools of 39-195 grams/day with transit times of 28-144 hours. (6)
Thus the diet rich in fiber helps to normalize pathologically slow or fast stool transit time.
Clinical trial showed that adding 30 g of oat bran to the healthy adult men diet decreases the stool transit time from 3.8 to 2.4 days, but in patients with diarrhea the time increases from some hours to 1.7 day.
In one of the studies food frequency questionnaire was used to assess the relation of fibre intake and frequency of colorectal adenoma. The study was done within the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, a randomised controlled trial designed to investigate methods for early detection of cancer. Fibre intake of 33971 participants who were sigmoidoscopy-negative for polyps was compared with 3591 cases with at least one histologically verified adenoma in the distal large bowel (ie, descending colon, sigmoid colon, or rectum). Odds ratios were estimated by logistic regression analysis. High intakes of dietary fibre were associated with a lower risk of colorectal adenoma, after adjustment for potential dietary and non-dietary risk factors. Participants in the highest quintile of dietary fibre intake had a 27% (95% CI 14-38, p(trend)=0.002) lower risk of adenoma than those in the lowest quintile. The inverse association was strongest for fibre from grains and cereals and from fruits. (7)
The European Prospective Investigation into Cancer and Nutrition (EPIC) study is a Europe-wide prospective cohort study of the relationships between diet and cancer, as well as other chronic diseases, such as cardiovascular disease. 521,457 healthy adults, mostly aged 35-70 years, were enrolled in ten European countries. It reported that a group with the highest fiber intake had a 25% reduction in the incidence of colon cancer compared to individuals with the lowest fiber intake. (8)